PEPSANON FIELD GUIDES · FOCUSED RESEARCH GUIDE

Peptides and Healthy Aging

Read mitochondrial, biomarker and longevity claims in context.

Adults evaluating claims about longevity, energy, mitochondrial function and biological aging

9 sectionsAbout 7 minutesSource-linked

$49 USD · planned one-time price

Full edition prepared. Purchases open after independent review; no preorders or payment details are being collected.

Read research with its limits.

These AI-assisted educational guides are not personal treatment plans and have not received independent clinical approval. Do not start, stop or combine treatments because of a guide. Medical notice

INSIDE THE GUIDE

From the claim
to the source.

A selected-source guide to what the available human, animal and cell records can and cannot answer; no therapeutic ranking, dose schedule or claim of proven longevity benefit.

The complete edition includes

  • Readable explanations tied to original sources
  • Findings, applicability and important uncertainty
  • Focused questions and practical reading worksheets
  • A separate summary designed for printing
  1. 01Peptides and Healthy AgingIn the free preview
  2. 02Start with the outcome you care aboutIn the free preview
  3. 03Read mitochondrial findings in contextFull guide
  4. 04MOTS-c: a biomarker is not an interventionFull guide
  5. 05Telomeres, mechanisms and product identityFull guide
  6. 06Keep safety separate from plausibilityFull guide
  7. 07Questions readers can answer more preciselyFull guide
  8. 08Build your healthy-aging evidence sheetFull guide
  9. 09Sources, review gaps and editionIn the free preview

IMPORTANT BOUNDARIES

What the evidence
leaves open.

  • A change in ATP production, circulating peptide concentration or telomere length does not establish longer life, preserved independence or a useful treatment effect.
  • MOTS-c biomarker studies are not administration trials. Disease-specific elamipretide results cannot be generalized to healthy consumers. Epitalon, epithalamin and pineal extracts require separate identities.
  • Bounded source closure checked 27 October 2026 using the named full reports, publisher/PubMed records and available companion documents. This is not a systematic literature search or exhaustive integrity review. Protocol comparisons and specified access, overlap and translation checks remain unfinished.
  • AI-assisted editorial draft. Human editorial, qualified independent clinical, legal, reader-test and accessibility reviews are pending. Purchases and PDF downloads are not yet available.

Evidence scope: 2026-10-27 selected-source checks; not a systematic search. Web edition: 4 November 2026. The web update does not represent a new comprehensive literature search.

Edition and review records →

TRY THE READING EXPERIENCE

See the evidence before you buy.

Open the free preview →

Save a release preference in My guides

Release emails are not currently being sent.